John Greene

Insider Reports History

Location
51 Lime Street, London, United Kingdom
Signature
/s/ Elizabeth Ryland Waldinger
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Greene:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CRISPR Therapeutics AG Director Common Shares 7K $314K $44.85 Feb 26, 2025 Direct
Discover Financial Services EVP, Chief Financial Officer Common Stock 0 $0 $185.37 May 18, 2025 Direct
CRISPR Therapeutics AG Director Stock Option (Right to Buy) 13K Jun 5, 2025 Direct

Insider Reports Filed by John Greene

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRSP CRISPR Therapeutics AG Jun 5, 2025 1 $0 4 Jun 6, 2025 Director
DFS Discover Financial Services May 18, 2025 1 $0 4 May 19, 2025 EVP, Chief Financial Officer
CRSP CRISPR Therapeutics AG Feb 26, 2025 1 $314K 4 Feb 28, 2025 Director
DFS Discover Financial Services Feb 1, 2025 1 -$370K 4 Feb 4, 2025 EVP, Chief Financial Officer
DFS Discover Financial Services Jan 23, 2025 1 $0 4 Jan 27, 2025 EVP, Chief Financial Officer
DFS Discover Financial Services Dec 19, 2024 2 -$1.98M 4 Dec 23, 2024 EVP, Chief Financial Officer
CRSP CRISPR Therapeutics AG May 30, 2024 1 $0 4 May 31, 2024 Director
DFS Discover Financial Services Feb 22, 2024 2 $0 4 Feb 26, 2024 EVP, Chief Financial Officer
DFS Discover Financial Services Feb 1, 2024 2 -$1.31M 4 Feb 5, 2024 EVP, Chief Financial Officer
DFS Discover Financial Services Feb 1, 2024 2 -$1.31M 4 Feb 5, 2024 EVP, Chief Financial Officer
DFS Discover Financial Services Jan 26, 2024 1 -$3.75M 4 Jan 30, 2024 EVP, Chief Financial Officer
CRSP CRISPR Therapeutics AG Jun 8, 2023 1 $0 4 Jun 9, 2023 Director
DFS Discover Financial Services Feb 23, 2023 1 $0 4 Feb 27, 2023 EVP, Chief Financial Officer
DFS Discover Financial Services Feb 1, 2023 2 -$1.63M 4 Feb 3, 2023 EVP, Chief Financial Officer
DFS Discover Financial Services Aug 1, 2022 1 -$179K 4 Aug 3, 2022 EVP, Chief Financial Officer
CRSP CRISPR Therapeutics AG Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
DFS Discover Financial Services Feb 25, 2022 1 $0 4 Mar 1, 2022 EVP, Chief Financial Officer
DFS Discover Financial Services Feb 15, 2022 1 -$568K 4 Feb 17, 2022 EVP, Chief Financial Officer
DFS Discover Financial Services Feb 1, 2022 1 -$245K 4 Feb 3, 2022 EVP, Chief Financial Officer
DFS Discover Financial Services Aug 1, 2021 1 -$218K 4 Aug 3, 2021 EVP & Chief Financial Officer
CRSP CRISPR Therapeutics AG Jun 10, 2021 1 $0 4 Jun 14, 2021 Director